MMRN1 and cancer: The first wave of targeting ECM enzymes was motivated by the finding that cancer tissues show upregulated matrix metalloproteinase (MMP) levels, and it was thought that MMP-induced cleavage of ECM would promote the escape of cancer cells from the site of tumors 24,25 (Fig.1A).